The Chemours Company (CC) Institutional Ownership & Insider Trading

470 institutions reported holding The Chemours Company shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 8 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CCThe Chemours CompanyFollow CC — free

Specialty Chemicals · Basic Materials

—

Price chart with a free account

Market cap: 1.9B
P/E TTM: —
Dividend yield: 2.7%
52-week: —
Next earnings: 17 Feb, in 116 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

470 institutions held 90.2% of the shares. Across filers that reported both quarters, shares held changed +3.3%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	470	136	+3.3%	110	60	104	44
Mar 26	447	131	-3.5%	106	60	111	44
Dec 25	427	135	-6.5%	106	43	113	40
Sep 25	414	146	-2.9%	90	43	130	49
Jun 25	428	150	+8.4%	147	62	83	46
Mar 25	407	138	+9.6%	115	44	104	67
Dec 24	433	127	+1.2%	115	49	87	42
Sep 24	412	120	+3.9%	113	46	99	56

The Chemours Company — questions

Who owns The Chemours Company stock?: 470 institutions reported The Chemours Company shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (15.5%), VANGUARD PORTFOLIO MANAGEMENT LLC (7.0%), VANGUARD CAPITAL MANAGEMENT LLC (4.5%).
Are The Chemours Company insiders buying or selling?: 8 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from The Chemours Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.